US Stock MarketDetailed Quotes

BLUE bluebird bio

Watchlist
  • 0.689
  • +0.012+1.73%
Close Aug 23 16:00 ET
  • 0.690
  • +0.001+0.15%
Post 20:02 ET
132.74MMarket Cap-1093P/E (TTM)

About bluebird bio Company

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.

Company Profile

SymbolBLUE
Company Namebluebird bio
Listing DateJun 19, 2013
Issue Price17.00
Founded1992
CEOMr. Andrew Obenshain
MarketNASDAQ
Employees323
Fiscal Year Ends12-31
Address455 Grand Union Boulevard
CitySomerville
ProvinceMassachusetts
CountryUnited States of America
Zip Code02145
Phone1-339-499-9300
Websitehttp://www.bluebirdbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Andrew Obenshain
  • Director, President and Chief Executive Officer
  • 1.81M
  • Joseph Vittiglio
  • Chief Legal and Business Officer
  • --
  • O. James Sterling
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Richard A. Colvin
  • Chief Medical Officer
  • 1.36M
  • Thomas J. Klima
  • Chief Commercial and Operating Officer
  • 1.25M
  • Richard Paulson, M.B.A.
  • Director
  • --
  • Nick Leschly
  • Director
  • 27.31K
  • Michael Cloonan
  • Director
  • --
  • Dr. Elisabeth Leiderman, M.D.
  • Independent Director
  • 97.81K
  • Najoh Tita-Reid
  • Independent Director
  • 84.81K
  • Dr. John O. Agwunobi
  • Independent Director
  • 91.31K
  • Mark Vachon
  • Independent Director
  • 142.23K
  • Dr. Charlotte Jones-Burton
  • Independent Director
  • 108.87K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept CAR-T Therapy
CAR-T Therapy
Intraday+1.00%
Gene Editing
Gene Editing
Intraday+0.58%